ARTLVSXXII• 6 Months (Normalized)
ARTL vs XXII (Artelo Biosciences Inc. vs 22nd Century Group Inc.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-92.37%
Artelo Biosciences Inc.
Normalized Baseline0.00%
XXII Performance $1.33
-96.91%
22nd Century Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin ARTL LEADS
+4.54 pts
ARTL outperforming by 4.54 percentage points
ARTLXXII
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL XXII
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(121 dates)
| Date | ARTL Price | ARTL Gain (%) | XXII Price | XXII Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -92.37% | $1.33 | -96.91% | +4.54% |
| Sep 24, 2026 | $5.17 | -91.31% | $1.51 | -96.49% | +5.18% |
| Sep 23, 2026 | $7.31 | -87.71% | $2.34 | -94.56% | +6.85% |
| Sep 22, 2026 | $4.15 | -93.02% | $1.81 | -95.79% | +2.77% |
| Sep 21, 2026 | $4.10 | -93.11% | $1.77 | -95.88% | +2.77% |
| Sep 18, 2026 | $3.94 | -93.38% | $1.79 | -95.84% | +2.46% |
| Sep 17, 2026 | $3.97 | -93.33% | $1.77 | -95.88% | +2.55% |
| Sep 16, 2026 | $3.75 | -93.70% | $1.72 | -96.00% | +2.30% |
| Sep 15, 2026 | $5.34 | -91.02% | $1.80 | -95.83% | +4.81% |
| Sep 14, 2026 | $4.87 | -91.81% | $1.85 | -95.70% | +3.89% |
| Sep 11, 2026 | $5.43 | -90.87% | $1.99 | -95.37% | +4.50% |
| Sep 10, 2026 | $5.63 | -90.54% | $2.05 | -95.24% | +4.70% |
| Sep 09, 2026 | $5.98 | -89.95% | $2.13 | -95.05% | +5.10% |
| Sep 08, 2026 | $6.19 | -89.59% | $2.29 | -94.67% | +5.08% |
| Sep 04, 2026 | $6.04 | -89.85% | $2.45 | -94.30% | +4.45% |
Page 1 of 9